Pain Medications: Opioid Side Effects, Naloxone, Equianalgesia, Adjuvants

```markdown

Pain Medications: Opioid Side Effects, Naloxone, Equianalgesia, Adjuvants

What Is This?

This guide covers opioid analgesics—how they relieve pain, their side effects, how to reverse overdose (naloxone), how to switch between opioids safely (equianalgesia), and non-opioid drugs (adjuvants) that enhance pain control. Nurses, physicians, and pharmacists use this knowledge daily to manage pain while minimizing harm.

Why It Matters

Opioids are powerful but risky. Misuse causes respiratory depression, addiction, and death. Naloxone saves lives by reversing overdose. Equianalgesia prevents dosing errors when switching opioids. Adjuvants reduce opioid needs, lowering side effects. Mastering these concepts prevents harm and improves patient outcomes.

Core Concepts

1. Opioid Side Effects

Opioids bind to mu receptors in the CNS, causing analgesia but also predictable side effects: - Respiratory depression: Dose-dependent slowing of breathing. Life-threatening at high doses. - Constipation: Nearly universal. Tolerance does not develop. Requires prophylactic laxatives (e.g., senna + docusate). - Nausea/vomiting: Stimulates the chemoreceptor trigger zone. Often transient; treat with antiemetics (e.g., ondansetron). - Sedation: Early side effect; tolerance develops. Monitor for oversedation (e.g., using the Pasero Opioid-Induced Sedation Scale). - Pruritus: Histamine release (especially with morphine). Treat with antihistamines or switch opioids (e.g., to hydromorphone). - Urinary retention: Increased sphincter tone. Monitor intake/output; may require catheterization. - Tolerance/dependence: Higher doses needed over time. Physical dependence-addiction (addiction involves compulsive use despite harm).

2. Naloxone (Narcan)

• Mechanism: Pure opioid antagonist. Binds to mu receptors, displacing opioids. Reverses respiratory depression, sedation, and analgesia.
• Dosing:
• Overdose: 0.4–2 mg IV/IM/IN (intranasal). Repeat every 2–3 minutes until breathing resumes.
• Post-op reversal: 0.04–0.4 mg IV (titrate to avoid abrupt pain return).
• Duration: 30–90 minutes. Opioids may outlast naloxone; monitor for renarcotization.
• Administration: Intranasal (preferred for laypeople), IV (fastest onset), IM (slower but reliable).

3. Equianalgesia

• Definition: Dose of one opioid equivalent in pain-relieving effect to another. Used to switch opioids safely (e.g., morphine-hydromorphone).
• Key principles:
• Incomplete cross-tolerance: Patients tolerant to one opioid may need 25–50% lower dose of a new opioid.
• Route matters: IV morphine is 3x more potent than oral morphine (e.g., 10 mg IV = 30 mg PO).
• Equianalgesic table (approximate; adjust for individual response):

• Calculation example:
• Patient on morphine 60 mg PO q4h. Switch to hydromorphone PO.
• Step 1: Convert to 24-hour dose: 60 mg × 6 = 360 mg/day.
• Step 2: Use equianalgesic ratio: morphine 30 mg PO = hydromorphone 7.5 mg PO.
• Step 3: 360 mg morphine ÷ 30 = 12; 12 × 7.5 mg = 90 mg hydromorphone/day.
• Step 4: Reduce by 25–50% for cross-tolerance: 45–67.5 mg/day.
• Step 5: Divide into q4h doses: 7.5–11.25 mg q4h.

4. Adjuvant Analgesics

Non-opioid drugs that enhance analgesia, reduce opioid requirements, or treat specific pain types: - Antidepressants: - TCAs (e.g., amitriptyline): Neuropathic pain (e.g., diabetic neuropathy). Start low (10–25 mg at bedtime). - SNRIs (e.g., duloxetine): Fibromyalgia, chronic musculoskeletal pain. Dose: 30–60 mg/day. - Anticonvulsants: - Gabapentin/pregabalin: Neuropathic pain (e.g., postherpetic neuralgia). Start gabapentin at 300 mg TID; titrate to 1800–3600 mg/day. - Local anesthetics: - Lidocaine patch: Postherpetic neuralgia. Apply to intact skin for 12 hours/day. - NMDA antagonists: - Ketamine: Refractory neuropathic pain. Low-dose IV (0.1–0.5 mg/kg/hr) or oral (e.g., 10–25 mg q8h). - Corticosteroids: - Dexamethasone: Bone pain (e.g., metastases), nerve compression. Dose: 4–8 mg/day (short-term use).

How It Works

Opioid Mechanism

1. Binding: Opioids bind to mu, delta, and kappa receptors in the CNS and periphery.
2. Signal modulation: Inhibit adenylate cyclase-? cAMP-? neurotransmitter release (e.g., substance P, glutamate).
3. Pain relief: Reduce nociceptive transmission in the spinal cord and brain.
4. Side effects: Mu receptor activation in the brainstem-respiratory depression; in the gut-constipation.

Naloxone Reversal

1. Competitive antagonism: Naloxone has higher affinity for mu receptors than opioids.
2. Displacement: Kicks opioids off receptors, restoring normal neurotransmission.
3. Onset: IV: 1–2 minutes; IN: 2–5 minutes.
4. Duration: Shorter than most opioids-risk of renarcotization.

Equianalgesic Switching

1. Calculate total daily dose of current opioid.
2. Convert using equianalgesic ratios.
3. Reduce by 25–50% for cross-tolerance.
4. Divide into new dosing schedule.
5. Monitor for over/undersedation.

Hands-On / Getting Started

Prerequisites

• Basic pharmacology knowledge (e.g., receptor types, routes of administration).
• Access to a drug reference (e.g., Lexicomp, UpToDate).
• Clinical setting (e.g., hospital, clinic) for real-world application.

Step-by-Step: Administering Naloxone for Overdose

1. Assess: Check for respiratory depression (RR < 8/min), pinpoint pupils, unresponsiveness.
2. Call for help: Activate emergency response (e.g., code blue).
3. Administer naloxone:
4. IN: 4 mg (one spray) in one nostril. Repeat in 2–3 minutes if no response.
5. IM/IV: 0.4 mg. Repeat every 2–3 minutes up to 10 mg.
6. Support breathing: Use bag-valve mask if RR < 8.
7. Monitor: Watch for renarcotization (may need repeat doses or infusion).

Step-by-Step: Equianalgesic Conversion

Scenario: Patient on morphine 10 mg IV q4h. Switch to oral oxycodone.
1. Calculate 24-hour dose: 10 mg × 6 = 60 mg IV morphine/day.
2. Convert IV morphine to PO morphine: 60 mg IV × 3 = 180 mg PO morphine/day.
3. Convert PO morphine to PO oxycodone: 180 mg morphine ÷ 1.5 = 120 mg oxycodone/day.
4. Reduce by 25% for cross-tolerance: 120 mg × 0.75 = 90 mg oxycodone/day.
5. Divide into q4h doses: 90 mg ÷ 6 = 15 mg oxycodone q4h.

Expected Outcome

• Naloxone: Patient regains consciousness, RR > 10/min, pupils dilate.
• Equianalgesic switch: Patient achieves similar pain control with new opioid.

Common Pitfalls & Mistakes

1. Ignoring incomplete cross-tolerance
2. Mistake: Converting opioids 1:1 without reducing dose.

3. Fix: Always reduce new opioid dose by 25–50%.

4. Overlooking naloxone duration

5. Mistake: Assuming one dose is enough.

6. Fix: Monitor for renarcotization (especially with long-acting opioids like methadone).

7. Mismanaging opioid-induced constipation (OIC)

8. Mistake: Waiting for symptoms before treating.

9. Fix: Start laxatives (e.g., senna + docusate) prophylactically.

10. Misusing adjuvant analgesics

11. Mistake: Using gabapentin for nociceptive pain (e.g., post-op pain).

12. Fix: Reserve adjuvants for neuropathic pain or specific indications (e.g., fibromyalgia).

13. Failing to titrate opioids

14. Mistake: Keeping patients on fixed doses despite inadequate pain control.
15. Fix: Increase dose by 25–50% every 24 hours until pain controlled or side effects limit.

Best Practices

Opioid Safety

• Start low, go slow: Titrate opioids gradually (e.g., increase by 25–50% every 24 hours).
• Use multimodal analgesia: Combine opioids with NSAIDs, acetaminophen, or adjuvants to reduce opioid needs.
• Monitor sedation: Use scales (e.g., Pasero Sedation Scale) to assess for oversedation.
• Prevent OIC: Prescribe laxatives (e.g., senna + docusate) with every opioid prescription.
• Avoid meperidine: Risk of neurotoxicity (seizures) and serotonin syndrome.

Naloxone Use

• Stock naloxone: Keep in all clinical areas where opioids are administered.
• Train staff: Ensure all providers know how to administer naloxone.
• Discharge with naloxone: Prescribe for high-risk patients (e.g., history of overdose, high-dose opioids).

Equianalgesia

• Double-check calculations: Use a calculator or reference table to avoid errors.
• Round doses: Use practical dosing (e.g., 15 mg oxycodone instead of 14.7 mg).
• Monitor closely: After switching opioids, assess pain and sedation frequently.

Adjuvant Use

• Match drug to pain type: Use gabapentin for neuropathic pain, not nociceptive pain.
• Titrate slowly: Start low (e.g., gabapentin 300 mg TID) and increase gradually.
• Monitor for side effects: TCAs (e.g., amitriptyline) can cause dry mouth, sedation, or QT prolongation.

Tools & Frameworks

Real-World Use Cases

1. Post-Operative Pain Management

• Scenario: Patient s/p total knee replacement with severe pain (8/10).
• Approach:
• Start with multimodal analgesia: acetaminophen + NSAID + opioid (e.g., hydromorphone 0.5 mg IV q4h PRN).
• Add gabapentin for neuropathic component (e.g., 300 mg TID).
• Monitor sedation and respiratory rate; adjust opioid dose as needed.
• Discharge with oral opioids (e.g., oxycodone 5 mg q6h PRN) + laxatives.

2. Chronic Cancer Pain

• Scenario: Patient with metastatic bone pain on morphine 60 mg PO q4h, but constipation is intolerable.
• Approach:
• Switch to transdermal fentanyl (e.g., 25 mcg/hr patch) for smoother analgesia and less constipation.
• Calculate equianalgesic dose: 60 mg morphine q4h = 360 mg/day = ~100 mcg/hr fentanyl patch.
• Reduce by 25% for cross-tolerance: 75 mcg/hr patch.
• Add dexamethasone 4 mg/day for bone pain.
• Prescribe naloxone for home use (high opioid dose).

3. Opioid Overdose in the ED

• Scenario: Unresponsive patient with pinpoint pupils and RR 4/min. History of heroin use.
• Approach:
• Administer naloxone 0.4 mg IV. If no response in 2 minutes, repeat up to 10 mg.
• Support ventilation with bag-valve mask.
• Start naloxone infusion (e.g., 0.4 mg/hr) if long-acting opioid suspected (e.g., methadone).
• Admit for observation (risk of renarcotization).

Check Your Understanding (MCQs)

Question 1

A patient on morphine 30 mg PO q4h is switched to hydromorphone PO. Using equianalgesia, what is the most appropriate starting dose of hydromorphone q4h?

A) 2 mg B) 4 mg C) 6 mg D) 8 mg

Correct Answer: B) 4 mg Explanation: - 24-hour morphine dose: 30 mg × 6 = 180 mg. - Equianalgesic ratio: morphine 30 mg PO = hydromorphone 7.5 mg PO. - 180 mg morphine ÷ 30 = 6; 6 × 7.5 mg = 45 mg hydromorphone/day. - Reduce by 25% for cross-tolerance: 45 mg × 0.75 = 33.75 mg/day. - Divide into q4h doses: 33.75 mg ÷ 6 = 5.625 mg-round to 4 mg q4h. Why the Distractors Are Tempting: - A) 2 mg: Too low; ignores equianalgesic ratio. - C) 6 mg: No reduction for cross-tolerance. - D) 8 mg: Overdose risk; no reduction applied.

Question 2

A patient receives naloxone 0.4 mg IV for opioid overdose. They wake up but become unresponsive again 30 minutes later. What is the most likely explanation?

A) Allergic reaction to naloxone B) Renarcotization C) Hypoglycemia D) Seizure

Correct Answer: B) Renarcotization Explanation: - Naloxone duration (30–90 minutes) is shorter than most opioids (e.g., morphine, methadone). - Opioids may outlast naloxone, causing recurrent respiratory depression. Why the Distractors Are Tempting: -